| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Longitudinal Evaluation of the Preferences of Patients With Advanced Cancer for Quality of Life and Survival in Malaysia: A Discrete Choice Experiment
|
Yong, Alene Sze Jing
|
|
|
26 |
12 |
p. 1772-1781
|
artikel
|
| 2 |
An Intersectional Approach to Quantifying the Impact of Geographic Remoteness and Health Disparities on Quality-Adjusted Life Expectancy: Application to Australia
|
Lee, Peter
|
|
|
26 |
12 |
p. 1763-1771
|
artikel
|
| 3 |
An Updated Review of Food and Drug Administration Warning and Untitled Letters for Clinical Outcome Assessment Claims Between 2013 and 2021
|
Sams, Lara
|
|
|
26 |
12 |
p. 1675-1680
|
artikel
|
| 4 |
Care Pathway Analysis to Inform the Earliest Stages of Technology Development: Scoping Oncological Indications in Need of Innovation
|
Scholte, Mirre
|
|
|
26 |
12 |
p. 1744-1753
|
artikel
|
| 5 |
Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report
|
|
|
|
26 |
12 |
p. 1811
|
artikel
|
| 6 |
Comparative Efficacy of Venetoclax-Based Combination Therapies and Other Therapies in Treatment-Naive Patients With Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy: A Network Meta-Analysis
|
Li, Xue
|
|
|
26 |
12 |
p. 1689-1696
|
artikel
|
| 7 |
Copyright/Subscription
|
|
|
|
26 |
12 |
p. v
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
26 |
12 |
p. vi
|
artikel
|
| 9 |
Faster Diagnosis and Treatment for Cancer: Assessing Patient Pathways Using a Panel Regression Analysis of the English National Cancer Registration Data
|
González-Esquerré, Júlia
|
|
|
26 |
12 |
p. 1730-1737
|
artikel
|
| 10 |
Has the Centers for Medicare & Medicaid Services Implicitly Adopted a Value Framework for Medicare Drug Price Negotiations?
|
Sullivan, Sean D.
|
|
|
26 |
12 |
p. 1686-1688
|
artikel
|
| 11 |
How Do Patients With Type 2 Diabetes Mellitus Value the Importance of Outcomes? An Overview of Reviews
|
Niño-de-Guzmán, Ena
|
|
|
26 |
12 |
p. 1782-1794
|
artikel
|
| 12 |
Preferences for Palliative and End-of-Life Care: A Systematic Review of Discrete Choice Experiments
|
Xia, Qing
|
|
|
26 |
12 |
p. 1795-1809
|
artikel
|
| 13 |
Projecting the Economic Impact of Compensating Living Kidney Donors in the United States: Cost-Benefit Analysis Demonstrates Substantial Patient and Societal Gains
|
|
|
|
26 |
12 |
p. 1810
|
artikel
|
| 14 |
Psychometric Comparison of EQ-5D-Y, CHU-9D, and PedsQL 4.0 in Chinese Children and Adolescents With Functional Dyspepsia: A Multicenter Study
|
He, Siyu
|
|
|
26 |
12 |
p. 1754-1762
|
artikel
|
| 15 |
Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial Approach
|
Serra-Burriel, Miquel
|
|
|
26 |
12 |
p. 1721-1729
|
artikel
|
| 16 |
Reflecting Parameter Uncertainty in Addition to Variability in Constrained Healthcare Resource Discrete Event Simulations: Worth Going the Extra Mile or a Road to Nowhere?
|
Squires, Hazel
|
|
|
26 |
12 |
p. 1738-1743
|
artikel
|
| 17 |
Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0
|
|
|
|
26 |
12 |
p. 1811
|
artikel
|
| 18 |
Section 50 of the Inflation Reduction Act Drug Price Negotiation Program: Considerations for the Centers for Medicare & Medicaid Services, Manufacturers, and the Health Economics and Outcomes Research Community
|
O’Brien, John M.
|
|
|
26 |
12 |
p. 1681-1685
|
artikel
|
| 19 |
Table of Contents
|
|
|
|
26 |
12 |
p. i-iv
|
artikel
|
| 20 |
The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non–Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis
|
Jansen, Jeroen P.
|
|
|
26 |
12 |
p. 1697-1710
|
artikel
|
| 21 |
The Relationship Between Pharmaceutical Innovation and Cancer Mortality in Spain, From 1999 to 2016
|
Lichtenberg, Frank R.
|
|
|
26 |
12 |
p. 1711-1720
|
artikel
|
Tijdschrift beschrijving